Vanillic acid prevents altered ion pumps, ions, inhibits Fas-receptor and caspase mediated apoptosis-signaling pathway and cardiomyocyte death in myocardial infarcted rats

Chemico-Biological Interactions

Volumn 232, Issue , 2015, Pages 68-76

  Stanely Mainzen Prince, Ponnian ^a   Dhanasekar, Koothan ^a   Rajakumar, Sundaresan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Antioxidant; Cardiac markers; Isoproterenol; Lipid peroxidation; Myocardial infarction; Vanillic acid

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CELL SURFACE RECEPTOR; CREATINE KINASE; CREATINE KINASE MB; FAS RECEPTOR; ISOPRENALINE; LACTATE DEHYDROGENASE; LIPID HYDROPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRYPAN BLUE; UNCLASSIFIED DRUG; URIC ACID; VANILLIC ACID; ADENOSINE TRIPHOSPHATASE; ANTIOXIDANT; BIOLOGICAL MARKER; FAS ANTIGEN; PROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GENE EXPRESSION; HEART INFARCTION; HEART MUSCLE CELL; HEART PROTECTION; ION TRANSPORT; LIPID PEROXIDATION; MALE; METABOLIC INHIBITION; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TREATMENT DURATION; URIC ACID BLOOD LEVEL; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTIGENS, CD95; ANTIOXIDANTS; APOPTOSIS; BIOLOGICAL MARKERS; CASPASES; GENE EXPRESSION REGULATION; LIPID PEROXIDATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; PROTECTIVE AGENTS; RATS, WISTAR; SIGNAL TRANSDUCTION; VANILLIC ACID;

EID: 84925703358     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2015.03.009     Document Type: Article

References (45)

1. World Health Organisation Reducing risks: Promoting Health Life: World Health Report, 2002 2005 WHO Geneva
2. M. Mari Kannan, and S. Darlin Quine Pharmacodynamics of ellagic acid on cardiac troponin-T, lysosomal enzymes and membrane bound ATPases: mechanistic clues from biochemical, cytokine and in vitro studies Chem. Biol. Interact. 193 2011 154 161
3. P. Stanely Mainzen Prince Preventive effects of (-) epicatechin on altered adenosine triphosphatases and minerals in isoproterenol induced myocardial infarcted rats J. Biochem. Mol. Toxicol. 26 2012 516 521
4. G. Olivetti, R. Abbi, F. Quaini, J. Kajstura, W. Cheng, J.A. Nitahara, E. Quaini, C. Di Loreto, C.A. Beltrami, S. Krajewski, J.C. Reed, and P. Anversa Apoptosis in the failing human heart N. Engl. J. Med. 336 1997 1131 1141
5. M. Van de Craen, P. Vandenabeecle, W. Declercq, I. Van den Brande, G. Van loo, F. Molemans, P. Schotte, W. Van Criekinge, R. Beyaert, W. Fiers, Characterization of seven murine caspase family members, FEBS Lett 403 (1997) 61-69.
6. E. Palojoki, A. Saraste, A.Eriksson, K.Pulki M.Kallajoki, L.Voipio-Pulkki, I. Tikkanen, Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats, Am. J. Physol. Heart Circ. Physiol. 280 (2001) H2726-H2731.
7. R.P. Rai, and M.S. Maurya Synthesis and evaluation of antibacterial activity of vanillin derivatives J. Sci. Technol. (Peshawar) 4 1966 275 276
8. P. Delaquis, K. Stanich, and P. Toivonen Effect of pH on the inhibition of Listeria spp. by vanillin and vanillic acid J. Food Prot. 68 2005 1472 1476
9. P. Stanely Mainzen Prince, K. Dhanasekar, and S. Rajakumar Preventive effects of vanillic acid on lipids, bax, bcl-2 and myocardial infarct size on isoproterenol - induced myocardial infracted rata: a biochemical and in vitro study Cardiovasc. Toxicol. 11 2011 58 66
10. P. Stanely Mainzen Prince, S. Rajakumar, and K. Dhanasekar Preventive effects of vanillic acid on electrocardiogram, lipid peroxidation, antioxidants, proinflammatory markers and histopathology in isoproterenol - induced cardiotoxic rats Eur. J. Pharmacol. 668 2011 233 240
11. Di. Witt, C. Trendelensurg. Creatine kinase -MB (CK-MB), Clin. Chem. Clin. Biochem. 20 (1982) 235.
12. D. Wei, E. Bhaar, B. Grossau, and B. Faderal Normal ranges of alpha HBDH, LDH, AP and LAP as measured with substrate optimated test charges Med Welt 26 1975 387 392
13. K. Yagi Lipid peroxides and human diseases Chem. Phys. Lipids 45 1987 337 351
14. Z.Y. Jiang, J.V. Hunt, and S.P. Wolff Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein Anal. Biochem. 202 1992 384 389
15. S.T. Omaye, T.O. Turnbull, and H.E. Sauberlich Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids D.B. McCormic, D.L. Wright, Methods of Enzymology 1979 Academic Press New York 3 11
16. H. Baker, O. Frank, B. de Angelis, and S. Feingold Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol Nutr. Rep. Int. 21 1980 531 536
17. G.L. Ellman Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 1959 70 77
18. S.L. Bonting Membrane and ion transport E.E. Bittar, Presence of Enzyme Systems in Mammalian Tissues Vol 1 1970 Wiley Interscience London 257 263
19. C.H. Fiske, and Y. Subbarow The colorimetric determination of phosphorus J. Biol. Chem. 66 1925 375 400
20. 2+-ATPase from erythrocyte membranes Biochim. Biophys. Acta 728 1983 281 288
21. 2+-ATPase activities in normal, regenerating and malignant cells Biochim. Biophys. Acta 684 1982 67 74
22. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin's phenol reagent J. Biol. Chem. 193 1951 265 275
23. W. Strober, Trypan blue exclusion test of cell viability, in R.Coico (Ed.) Current Protocols in Immunology, John Wiley and Sons, p. A3B1.
24. M. Mari Kannan, and S. Darlin Quine Mechanistic clues in the protective effect of ellagic acid against apoptosis and decreased mitochondrial respiratory enzyme activities in myocardial infarcted rats Cardiovasc. Toxicol. 2 2012 56 63
25. P.R. Brofman, K.A. Carvalho, L.C. Guarita-Souza, C. Rebelatto, P. Hansen, A.C. Senegaglia, N. Myague, M. Furuta, J.C. Francisco, and M. Olandoski Cellular transplant: functional, immunocytochemical and histopathologic analysis in an experimental model of ischemic heart disease using different cells Braz. J. Cardiovasc. Surg. 19 2004 261 266
26. L.C. Guarita- SouzaK. A. Carvalho, C. Rebelatto, A.C. Senegaglia, P. Hansen, M. Furuta, N. Miyague, J.C. Francisco, M. Olandoski, V. Woitowicz, R. Simeoni, J.R. Faria-Neto, P. Brofman, Comparison of mononuclear and mesenchymal stem cell transplantation in myocardial infarction. Braz. J. Cardiovasc. Surg. 20 (2005) 270-278.
27. S. Goldman, and T.E. Raya Rat infarct model of myocardial infarction and heart failure J. Card. Fail. 1 1995 169 177
28. R. Zhou, Q. Xu, P. Zheng, L. Yan, J. Zheng, and G. Dai Cardioprotective effect of fluvastatin on isoproterenol induced myocardial infarction in rat Eur. J. Pharmacol. 586 2008 244 250
29. V. Patel, A. Upaganlawar, R. Zalawadia, and R. Balaraman Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: A biochemical, electrocardiographic and histoarchitectural evaluation Eur. J. Pharmacol. 644 2010 160 168
30. K.H.S. Farvin, R. Anandan, S.H. Kumar, K.S. Shiny, T.V. Sankar, and T.K. Thangappan Effect of squalene on tissue defense system in isoproterenol induced myocardial infarction in rats Pharmacol. Res. 50 2004 231 236
31. T. Sangeetha, and S. Darlin Quine Antilipoperoxidative and antioxidant effects of S-allyl cysteine sulfoxide on isoproterenol induced myocardial infarction in Wistar rats J. Biochem. Mol. Toxicol. 20 2006 167 173
32. P.T. Devika, and P. Stanely Mainzen Prince Protective effect of (-)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: a histopathological study Biomed. Pharmacother. 62 2008 701 708
33. D.P. Zipes, Genesis of cardiac arrhythmias: electrophysiological considerations. in: Braunwald E (Ed.), Heart disease: A Textbook of Cardiovascular Medicine. Philadelphia: Saunders; 1992. pp 602-627.
34. C.D. Constantinides, D.L. Kraitchman, K.O. O'Brien, F.E. Boada, J. Gillen, and P.A. Bottomley Noninvasive quantification of total sodium concentrations in acute reperfused myocardial infarction using 23Na MRI Magn. Reson. Med. 46 2001 1144 1151
35. M. Marikannan, S. Darlin Quine, and T. Sangeetha Protective efficacy of ellagic acid on glycoproteins, blood hematology, biochemical changes, and electrolytes in myocardial infarcted rats J. Biochem. Mol. Toxicol. 26 2012 270 275
36. K.L. Hemalatha, and P. Stanely Mainzen Prince A biochemical and 2,3,5-triphenyl tetrazolium chloride staining study on the preventive effects of zingerone (vanillyl acetone) in experimentally induced myocardial infarcted rats Eur. J. Pharmacol. 746 2015 198 205
37. T.M. Buttke, and P.A. Sandstrom Oxidative stress as a mediator of apoptosis Immunology 15 1994 7 10
38. I. Jeremias, C. Kupatt, A. Martin-Villalba, H. Habazettl, J. Schenkel, P. Boekstegers, and K.M. Debatin Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia Circulation 102 2000 915 920
39. P. Lee, M. Sata, D.J. Lefer, S.M. Factor, Walsh, and K.R.N. Kitsis Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia reperfusion in vivo Am. J. Physiol. Heart Circ. Physiol. 284 2003 456 463
40. H. Kawakami, Y. Shigematsu, T. Ohtsuka, H. Okayama, Y. Hayashi, Y. Hara, K. Kodama, M. Hamada, and K. Hiwada Increased circulating soluble form of Fas in patients with dilated cardiomyopathy Jpn. Circ. J. 62 1998 873 876
41. T. Toyozaki, M. Hiroe, T. Saito, Y. Iijima, H. Takano, K. Hiroshima, H. Kohno, S. Ishiyama, F. Marumo, Y. Masuda, and H. Ohwada Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin, and in healthy volunteers Am. J. Cardiol. 81 1998 798 800
42. M.R. Bennett Apoptosis in the cardiovascular system Heart 87 2002 480 487
43. K. Kannan, and S.K. Jain Oxidative stress and apoptosis Pathophysiology 7 2000 153 163
44. T. Radhiga, C. Rajamanickam, A. Sundaresan, M. Ezhumalai, and K.V. Pugalendi Effect of ursolic acid treatment on apoptosis and DNA damage in isoproterenol-induced myocardial infarction Biochimie 94 2012 1135 1142
45. N.O. Concha, and S.S. Abdel-Meguid Controlling apoptosis by inhibition of caspases Curr. Med. Chem. 9 2002 713 726